Tensive Srl's Regenera, a bio-absorbable breast implant, promises to help the millions of women who undergo breast cancer surgery every year, to feel whole again. “While surgery will save many lives, ...

Remynd NV has turned in positive phase IIa data for a new target in Alzheimer’s disease, showing that restoring calcium ...

Health Canada posted a report on reduction of red tape, which includes a proposal for mutual recognition of other regulators’ inspections of device and drug manufacturing facilities.

Goodpath Inc., a virtual provider of whole-person care for chronic conditions, raised $18 million in series A financing, led ...

As Avidity Biosciences Inc. brought the second-largest follow-on offering of the year to the market, the company also ...

China was already making strides to lead the biotechnology industry in many key areas such as cell therapies and AI, but the ...

Drug developer stocks rebounded over July and August, with 23 companies on the BioWorld Drug Developers Index posting gains ...

Autosomal dominant polycystic kidney disease (PKD) is a chronic and debilitating condition affecting over 12 million patients ...

Fibrobiologics Inc. has announced IND-enabling updates from its psoriasis research program demonstrating the potential of ...

Dewpoint Therapeutics Inc. has closed its series D financing to advance DPTX-3186, a first-in-class condensate modulator ...

The American Medical Association has posted the latest update to the current procedural terminology code set, which deletes more than 80 existing codes and adds nearly 290 new codes. Among the new ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: B. Braun, Caolina Molecular, Modular Medical, Phenovista, Pulnovo, Science, Tailocare.